Carisma Therapeutics Inc Sustainability Reports
Carisma Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative cell immunotherapies. The company leverages its proprietary platform to engineer macrophages and monocytes to treat cancer, fibrosis, and other serious diseases.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300DGKHONOZQIY116
FIGI: BBG001V0GC35
1 reports from 2023 to 2023
